Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc.（TERN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
tern · 股价预测 · 16 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 16 位华尔街分析师
Buy
16 位分析师
共识
评级分布
12 个月目标价
High
$70.00
Consensus
$58.13
+9.8% upside
Low
$53.00
Median: $57 · Last Close: $52.95
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$58.13
9.8% upside
High Target
$70
32.2%
Low Target
$53
0.1%
Current Price
$52.95
as of today
Based on analyst price targets, the TERN stock price prediction for the next 12 months ranges from $53 to $70. The consensus TERN price forecast of $58.13 implies 9.8% upside from the current price of $52.95.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $52.88 | ↓ 0.14% |
1-day model range: $52.86–$52.89. Peak: $52.89 (-0.14%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TERN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-27 | Oppenheimer | Downgrade ↓ | Outperform→Perform |
| 2026-04-14 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-03-31 | Truist Securities | Downgrade ↓ | Buy→Hold |
| 2026-03-30 | Barclays | Downgrade ↓ | Overweight→Equal Weight |
| 2026-03-26 | Citizens | Downgrade ↓ | Market Outperform→Market Perform |
| 2026-03-26 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2026-03-25 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-12-11 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-09 | Barclays | Maintains | Overweight→Overweight |
| 2025-12-09 | Mizuho | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Terns Pharmaceuticals, Inc. (TERN) stock. Of the recent 79 rating actions, 2 were upgrades and 7 were downgrades. 16 analysts currently cover TERN.
分析师推荐趋势
TERN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 91.9% YoY
Revenue Next Year
$6M
↑ 500.7% YoY
EPS This Year
$-1.16
EPS Next Year
$-1.43
↑ 23.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast TERN EPS of $-1.16 for the current fiscal year, based on estimates from 3 analysts. The TERN revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
TERN 股价预测由两类独立数据源支撑：来自 16 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。TERN 的共识目标价为 $58.13（+9.8% 上行空间），分析师共识为 Buy。
TERN 的短期预测（明日）为 $52.88（-0.14%）。
Terns Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 TERN。TERN 在 2027 年的整体展望偏积极，在覆盖分析师中约 63% 对应 Buy 共识。
常见问题
TERN 预测 · 8 个问题根据 16 位华尔街分析师，TERN 的 12 个月平均目标价为 $58.13，最高 $70.00、最低 $53.00。若有图表，中位目标价可在上方查看。相对当前价 $52.95，隐含约 +9.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.